Potential use of erythromycin to prevent and treat prosthetic failure. - Wikidata - awgldk - TriplyDB

Potential use of erythromycin to prevent and treat prosthetic failure.

Potential use of erythromycin to prevent and treat prosthetic failure.

http://www.wikidata.org/entity/Q37691133

about

Review of periprosthetic osteolysis in total joint arthroplasty: an emphasis on host factors and future directions 'Old drugs for new applications': can orthopedic research benefit from this strategy?Inhibiting wear particles-induced osteolysis with naringin.

P2860

Q27009529-AB669072-1C0B-4724-8CDB-98F74DA2BB06 Q36056952-DA52BF81-AB79-4D68-9463-2AADF7014B0B Q36495023-E55DB2E2-4683-48F5-85EA-A9EEA906F428

P2860

Potential use of erythromycin to prevent and treat prosthetic failure.

http://www.wikidata.org/entity/Q37691133

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Potential use of erythromycin to prevent and treat prosthetic failure.

@en

Potential use of erythromycin to prevent and treat prosthetic failure.

@nl

type

label

Potential use of erythromycin to prevent and treat prosthetic failure.

@en

Potential use of erythromycin to prevent and treat prosthetic failure.

@nl

prefLabel

Potential use of erythromycin to prevent and treat prosthetic failure.

@en

Potential use of erythromycin to prevent and treat prosthetic failure.

@nl

P1433

Q37691133-12E8803C-1FC7-4395-81AD-6F391C1BCBF3

P1476

Q37691133-7ABBEE16-8649-46DA-8668-2958099E8B00

P2093

Q37691133-5A490D16-A5CC-494C-9538-65FED4EF1463

Q37691133-AA138D2B-CD22-42EB-8CC8-542A8180C041

P2860

Q37691133-5D31084C-A408-4CE1-85FD-B6457735082A

Q37691133-71A7401E-C97A-473B-A682-664459F81E3B

Q37691133-7431C6F8-D8E7-437E-9D4F-2C942EDE723F

Q37691133-7DB54DDB-4534-4C47-AA45-896BDB7EBF45

Q37691133-8814D0AF-79F4-4727-9EE3-526E67BAC854

Q37691133-B3651489-837A-4A40-8F33-ACFF8FFE6922

Q37691133-DACEDFF1-5A1B-4D64-B520-8CF33FF4B943

Q37691133-EAE37AB1-9D06-499A-9C82-51E503B0D30E

P304

Q37691133-5EE48015-15D0-4C01-9AE1-6130F551C35A

P31

Q37691133-49E6CD13-EBB0-4310-8A38-A1DB3A7F5A67

P356

Q37691133-736444CD-6EBB-48E8-B625-C7B9692F850D

P433

Q37691133-CF1024A8-BA3C-49E8-B695-550A6403BBB2

P478

Q37691133-8B9A4F0A-8B1D-4F03-B3C1-C5EFF58C0101

P577

Q37691133-BD40BAF4-751E-48F2-8B13-636BC69B74E1

P698

Q37691133-BCCAD22A-1082-4CE7-AF39-8A7B6260A6FB

P356

0091270009360535

P1433

The Journal of Clinical Pharmacology

P1476

Potential use of erythromycin to prevent and treat prosthetic failure.

@en

P2093

Ling Qin

http://www.w3.org/2001/XMLSchema#string

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts.

The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis.

Outcome following deep wound contamination in cemented arthroplasty.

Diagnosis and management of prosthetic joint infection.

Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation.

The microbiology of infected hip arthroplasty.

Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.

New injectable and radiopaque antibiotic loaded acrylic bone cements.

P304

858-860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270009360535

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20150525

http://www.w3.org/2001/XMLSchema#string